Correlation Between Vivani Medical and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vivani Medical and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivani Medical and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivani Medical and Inhibikase Therapeutics, you can compare the effects of market volatilities on Vivani Medical and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivani Medical with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivani Medical and Inhibikase Therapeutics.
Diversification Opportunities for Vivani Medical and Inhibikase Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vivani and Inhibikase is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Vivani Medical and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Vivani Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivani Medical are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Vivani Medical i.e., Vivani Medical and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Vivani Medical and Inhibikase Therapeutics
Given the investment horizon of 90 days Vivani Medical is expected to under-perform the Inhibikase Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Vivani Medical is 2.05 times less risky than Inhibikase Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Inhibikase Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 159.00 in Inhibikase Therapeutics on September 13, 2024 and sell it today you would earn a total of 170.00 from holding Inhibikase Therapeutics or generate 106.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vivani Medical vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Vivani Medical |
| Inhibikase Therapeutics |
Vivani Medical and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vivani Medical and Inhibikase Therapeutics
The main advantage of trading using opposite Vivani Medical and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivani Medical position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Vivani Medical vs. PepGen | Vivani Medical vs. Tyra Biosciences | Vivani Medical vs. Entrada Therapeutics | Vivani Medical vs. Pharvaris BV |
| Inhibikase Therapeutics vs. Puma Biotechnology | Inhibikase Therapeutics vs. Iovance Biotherapeutics | Inhibikase Therapeutics vs. Sarepta Therapeutics | Inhibikase Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |